Earlier litigation involving Victoza and other incretin mimetics included claims that the drug was linked to pancreatic cancer, pancreatitis, and other serious conditions, and some of these claims were consolidated in federal court, though many were dismissed or resolved years ago
"I am interested in the cardiovascular protective effects of GLP-1 receptor agonists given my family history of heart disease" is a perfectly valid opening statement
In this way, we must differentiate the areas that need volume reduction from the areas that need replacement, in order to naturally restructure the aged face
Weight loss changes the way bones are loaded, and if nutrition and exercise arent managed carefully, density can decline
As the science continues to evolve, were seeing that these benefits may extend to people who dont necessarily need to lose weight, and thats opened up an interesting conversation about why people are microdosing GLP-1 medications